Research output per year
Research output per year
Personal profile
Nivel SNI
- SNI 1
Fingerprint
Dive into the research topics where Laura Esther Tijerina Rodríguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Manual de Laboratorio de Microbiología y Parasitología Médica
Tijerina Rodríguez, L. E., 2023, (In preparation)Research output: Book/Report › Scholarly edition
-
Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
Tijerina-Rodríguez, L., Garza-González, E., Martínez-Meléndez, A., Morfín-Otero, R., Camacho-Ortiz, A., Gonzalez-Diaz, E., Perez-Gomez, H. R., Villarreal-Treviño, L., Maldonado-Garza, H., Esparza-Ahumada, S. & Rodríguez-Noriega, E., Feb 2022, In: Biomedical Journal. 45, 1, p. 200-205 6 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus) -
Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?
Garrido-Treviño, L. F., López-Martínez, M., Flores-Hinojosa, J. A., Tijerina-Rodríguez, L. & Bosques-Padilla, F., 2022, In: Revista de gastroenterologia de Mexico (English). 87, 3, p. 330-341 12 p.Research output: Contribution to journal › Review article › peer-review
-
Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H. pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?
Translated title of the contribution :Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods? Research output: Contribution to journal › Review article › peer-review
Open Access4 Citations (Scopus) -
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Martínez-Meléndez, A., Tijerina-Rodríguez, L., Collins, N., Baines, S. D., Morfin-Otero, R., Camacho-Ortíz, A., Villarreal-Treviño, L. & Garza-González, E., Dec 2021, In: Microbial Drug Resistance. 27, 12, p. 1672-1676 5 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
Prizes
-
-
File
-
"Premio Jesús Kumate" 1° Lugar Investigación Biomédica
Tijerina Rodríguez, Laura Esther (Recipient), 2018
Prize
-
Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates
Laura Esther Tijerina Rodríguez (Speaker)
2019Activity: Talk or presentation types › Oral presentation
-
Evaluación de características epidemiológicas de pacientes mayores de 65 años con diarrea por Clostridium difficile
Laura Esther Tijerina Rodríguez (Speaker)
2019Activity: Talk or presentation types › Oral presentation
-
Sobreexpresión de genes reguladores de esporulación y biopelícula en infecciones por C. difficile recurrente
Laura Esther Tijerina Rodríguez (Speaker)
2019Activity: Talk or presentation types › Oral presentation
-
Enhanced Sporulation and Vancomycin Resistance Associated with Clostridium difficile from Recurrent Infections
Laura Esther Tijerina Rodríguez (Speaker)
2018Activity: Talk or presentation types › Oral presentation
-
Identificación de factores de virulencia de Clostridium difficile asociados a la infección recurrente
Laura Esther Tijerina Rodríguez (Speaker)
2018Activity: Talk or presentation types › Oral presentation